Correlation Between Adaptive Biotechnologies and Beam Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Beam Therapeutics, you can compare the effects of market volatilities on Adaptive Biotechnologies and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Beam Therapeutics.
Diversification Opportunities for Adaptive Biotechnologies and Beam Therapeutics
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adaptive and Beam is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Beam Therapeutics go up and down completely randomly.
Pair Corralation between Adaptive Biotechnologies and Beam Therapeutics
Given the investment horizon of 90 days Adaptive Biotechnologies Corp is expected to generate 1.14 times more return on investment than Beam Therapeutics. However, Adaptive Biotechnologies is 1.14 times more volatile than Beam Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Beam Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 512.00 in Adaptive Biotechnologies Corp on August 30, 2024 and sell it today you would earn a total of 61.00 from holding Adaptive Biotechnologies Corp or generate 11.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptive Biotechnologies Corp vs. Beam Therapeutics
Performance |
| Timeline |
| Adaptive Biotechnologies |
| Beam Therapeutics |
Adaptive Biotechnologies and Beam Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptive Biotechnologies and Beam Therapeutics
The main advantage of trading using opposite Adaptive Biotechnologies and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |